Faculty Opinions recommendation of Association of ctDNA tumor fraction with survival in advanced non-small cell lung cancer (NSCLC) treated with maintenance durvalumab in the UNICANCER SAFIR02-Lung/IFCT1301 trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature（2023）
关键词
ctdna tumor fraction,cell lung cancer,lung cancer,maintenance durvalumab,non-small
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要